YSG's first participation at WCD, with two major brands
Retrieved on:
Friday, July 28, 2023
Cream, Molecule, International League, Exhibition, Chinese Medical Doctor Association, YSG, University, Gregory Mandel, Acne, Medicine, Research, History, Element, Snow, Multimedia, Trial of the century, Congress, Hospital, Beauty, Galenic, Patent, Laboratory, Couture, The International League of Dermatological Societies, Growth, Diagnosis, Innovation, SCI, VC, Human, ILDS, Skin, Safety, Pharmaceutical industry, Management, Fine chemical, Medical device, Entertainment, Seaweed, Dermatology, WCD
The innovative ideas of beauty technology have been approached and approved by many dermatologists and professors from all over the world.
Key Points:
- The innovative ideas of beauty technology have been approached and approved by many dermatologists and professors from all over the world.
- In 2022, the Company upgraded its annual R&D expense ratio to 3.4%, which continued to be in the front rank globally.
- YSG's participation in WCD will be an important step in the layout of its global R&D system.
- While exhibiting its remarkable dual clinical study at the WCD, it is also celebrating the brand's 20th anniversary in Singapore.